WHO ICTRP trial
The role of inFLAmation in brain and behavIouR in overweight and obesity: the…
NL-OMON54343 · Overview of Medical Research in the Netherlands (NL-OMON) · Recruiting
Key facts
| Trial ID | NL-OMON54343 |
|---|---|
| Public title | The role of inFLAmation in brain and behavIouR in overweight and obesity: the FLAIR-o study. |
| Scientific title | The role of inFLAmation in brain and behavIouR in overweight and obesity: the FLAIR-o study. - FLAIR-o |
| Primary sponsor | Radboud Universiteit Nijmegen |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Recruiting |
| Study type | Observational invasive |
| Countries | The Netherlands |
| Conditions | obesity overweight;10003018;obesity;overweight |
| Interventions | During the intervention period of 12 weeks, participants included in the trial will receive 1 tablet of 0.5mg colchicine or placebo per day. ;fMRI;inflammation;motivation;obesity |
| Registration date | Sep 13, 2023 |
| Target size | 150 |
| Secondary IDs | NL77503.091.21 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: